The leadership team at CrownBio has a deep understanding of the pharmaceutical industry, and significant experience in building and operating businesses and major departments within the top US Pharmaceutical's R&D and preclinical programs. Our objective is to deliver innovative, cost-effective preclinical and translational research services and tools to power our customers discovery and development programs.
